CGC Canopy Growth Corporation
USHealthcareAs of 2026-07-08 16:00
Why CGC matters now
Canopy Growth Corporation (CGC) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.97 with +1.59% on the session and $407.4M in market capitalization; recent performance reads 1-month -2.28% and YTD -15.16%.
The latest financial table shown here is FY 2025, with revenue of $346.8M, net income of $-262.9M, and EPS of $-0.88. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -30.8%.
The latest indexable market news headline is "Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?" from The Motley Fool.
Additional event context on this page matters because analyst consensus is Hold with a median target of $11.02; recent insider activity includes Lazzarato David Angelo filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.68
P/S
0.81
EV/EBITDA
-2.60
DCF Value
$-0.72
FCF Yield
-30.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.6%
Operating Margin
-23.5%
Net Margin
-84.8%
ROE
-35.5%
ROA
-23.6%
ROIC
-7.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| FY 2025 | $346.8M | $-262.9M | $-0.88 |
| Q3 2025 | $102.3M | $-85.9M | $-0.25 |
| Q2 2025 | $66.7M | $-1.6M | $-0.01 |
| Q1 2025 | $72.1M | $-41.5M | $-0.22 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$14.47
Target (Median)
$11.02
Target Range
$8.00 - $27.85
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Exchange
—
Beta
2.41
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.